🇺🇸

US SEC Filing Intelligence

· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 07, 2026

This digest covers a single filing from Greenlane Holdings, Inc., which falls squarely within the Bankruptcy & Insolvency stream. The company’s 8-K reveals that four subsidiaries made assignments for the benefit of creditors (ABCs) under Florida law, effectively transferring substantially all assets to an assignee for liquidation. This action results in deconsolidation, removing $594,573 in assets and $3,754,180 in liabilities from the balance sheet, though liabilities are not discharged. Pro forma financials show a dramatic 95% revenue decline from $4.355M to $225,000 for FY2025, while net loss improves from $85.580M to $48.117M due to the removal of subsidiary losses. Critically, the parent company received no consideration for the assignments and continues to report significant operating losses and unrealized losses on digital assets, indicating a deeply distressed financial position. The negative sentiment and high materiality (9/10) underscore a severe solvency crisis with no apparent turnaround path, making this a high-risk event for stakeholders.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 07, 2026

The October 7, 2026, board room change filings reveal a significant wave of corporate restructuring and leadership transitions across the US market, with a notable concentration in the industrial and technology sectors. The most critical development is Corteva's successful spin-off of its seed business into Vylor Inc., a major strategic move that triggered a complete board and C-suite overhaul, representing the highest materiality event in this batch. A clear pattern of orderly CFO transitions is evident, with FuelCell Energy, Alkami Technology, and Advasa Holdings all announcing CFO changes with structured transition periods, suggesting proactive succession planning rather than crisis-driven departures. The data also shows a trend of appointing directors with deep operational and regulatory expertise, such as Dr. Jeong H. Kim at Crane NXT (former Bell Labs President) and Donald Slager at WillScot (former Republic Services CEO), signaling a focus on governance strengthening. While no period-over-period financial comparisons were available in these specific filings, the forward-looking data on executive compensation packages (e.g., Hims & Hers' $3M RSU grant to new CAO) and separation agreements (e.g., Matternet's $156K CFO severance) provide actionable intelligence on company financial health and talent retention strategies. The mixed sentiment at BiomX/Tessera, with its going concern qualification and performance-based CEO equity awards, represents the highest-risk situation requiring immediate investor attention.

17 high priority 17 total filings
· daily

USA Insider Trading Pulse — October 07, 2026

The October 7, 2026 insider trading pulse reveals a market dominated by routine equity awards and tax-withholding dispositions, masking a clear divergence in conviction. Vail Resorts issued a massive wave of stock appreciation rights and restricted stock units to its entire executive suite and board, signaling a long-term retention strategy but no immediate cash conviction. The most actionable signal is the aggressive accumulation by IRIDEX Corp's 10% owner, Lin Shih-Yao David, who has been buying consistently at sub-$1 prices, building a stake now exceeding 1.1 million shares. On the bearish side, a cluster of high-value, pre-planned insider sales at Vaxcyte, Applied Optoelectronics, and Intapp suggests insiders are monetizing gains at elevated valuations. The financial sector shows mixed signals, with Provident Financial Holdings seeing only tax-related dispositions, while Capital One's General Counsel executed a notable 10b5-1 sale. Overall, the period is characterized by heavy award activity in the leisure sector, cautious selling in high-growth tech, and a single, highly-convicted buyer in the micro-cap medical device space.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — October 07, 2026

The October 7, 2026, M&A landscape is dominated by two definitive SPAC business combination agreements (First Digital/FDUSD and KQC Quantum) and a major SPAC IPO (Pine Tree Acquisition Corp.), signaling sustained appetite for bringing high-growth, non-traditional assets to public markets via blank-check vehicles. A key period-over-period trend is the divergence in SPAC health: while new capital is flowing into the space via IPOs, existing SPACs like Launch Two and Columbus Acquisition are showing signs of distress, with repeated meeting postponements and opaque post-merger filings, respectively. The most critical development is the $250 million valuation of First Digital, a stablecoin issuer with $87M in FY2025 revenue, which will test regulatory and market appetite for crypto-native public listings. Meanwhile, Richardson Electronics stands out as a rare operating company in the batch, delivering strong 18.9% YoY revenue growth and 112.6% net income surge, contrasting with the speculative nature of the SPAC filings. A portfolio-level pattern is the concentration of risk in SPACs facing tight deadlines (Charlton Aria must close by Oct 25, 2026) and shareholder redemption pressures, creating binary outcomes for investors. The absence of insider trading activity in the SPAC filings, except for the Sponsor's nominal $0.003/share founder share purchase in Southport II, suggests limited management conviction beyond the deal structure itself.

8 high priority 8 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 07, 2026

Overnight filings reveal a mixed picture for US markets, headlined by a major SPAC deal in digital assets and a critical delisting. First Digital's $250M business combination with CSLM Digital Asset Acquisition Corp brings stablecoin exposure to Nasdaq, while NUSATRIP's imminent delisting serves as a stark warning on micro-cap risk. The most significant period-over-period trend comes from Costco, which reported a robust 10% YoY revenue growth to $297B, though gross margins saw slight compression. Conversely, Odyssey Marine Exploration's financials show a severe deterioration, with revenue halving and losses widening. Insider activity was largely neutral, dominated by routine stock awards and tax-withholding sales at MGM Resorts and Kenvue. A notable capital allocation move was the $61.8M equity investment in Gogoro, signaling confidence in the EV space. The most actionable intelligence centers on the First Digital SPAC, Costco's steady growth, and the risk flags around Odyssey Marine and NUSATRIP.

28 high priority 22 medium 50 total filings
· daily

Biotech Small-Cap Approvals — October 06, 2026

The October 6, 2026 period saw 4 FDA approvals, all classified as 'Other' (FALLBACK type), with zero NMEs, biosimilars, or label expansions. The dominant theme is a single label expansion for EVER VALINJECT (sponsor: Unknown), which generated the only bullish signal, albeit with no disclosed commercial details. The remaining three approvals are biosimilar entries for LEVOCARNITINE (GLAND), PHYTONADIONE (LUPIN), and LOPERAMIDE HYDROCHLORIDE (TARO), all rated neutral due to the lack of disclosed peak sales, exclusivity, or pricing data. The highest-conviction signal is the EVER VALINJECT label expansion, but its investment implication is opaque without indication size or market position data. Key risk is the absence of NME approvals, signaling a low-innovation period for small-cap biotech, and the lack of disclosed commercial details across all approvals limits actionable analysis.

4 total filings
· daily

New Drug Approvals (Original) — October 06, 2026

During the October 6, 2026 period, the FDA approved 4 non-NME, non-biosimilar, non-label-expansion drugs (classified as 'Other'), with a mixed signal profile of 1 bullish and 3 neutral. The period lacked any high-value NME or biosimilar approvals, resulting in minimal therapeutic area clustering or pipeline momentum signals. The only bullish signal came from EVER VALINJECT's label expansion for an undisclosed indication, but the lack of commercial data (peak sales, pricing, market position) limits conviction. The remaining approvals—LEVOCARNITINE (GLAND), PHYTONADIONE (LUPIN), and LOPERAMIDE HYDROCHLORIDE (TARO)—are neutral biosimilar entries in mature markets with no disclosed sales estimates, offering limited investment differentiation. Key watch items include the absence of NMEs, which signals a quiet approval cadence, and the need for further disclosure on EVER VALINJECT's commercial potential.

4 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 06, 2026

The 10 filings from the S&P 500 Technology sector reveal a bifurcated insider sentiment landscape. Accenture plc shows a pattern of routine, low-materiality equity awards to its entire C-suite, signaling stable management retention and alignment at a set price of $196.76. In stark contrast, both Synopsys Inc and CrowdStrike Holdings report high-value insider stock sales by key executives, including a Deputy CFO and the CEO, respectively. The Synopsys sale ($4.59M) by the Deputy CFO & CAO is particularly bearish, representing a significant liquidation of holdings. CrowdStrike’s CEO sales ($1.38M) are executed under a Rule 10b5-1 plan, which provides a layer of insulation from direct sentiment interpretation but still represents a notable reduction in personal exposure. No period-over-period comparisons, forward-looking guidance, capital allocation changes, or M&A activity were present in this batch, limiting the analysis to insider transaction patterns. The dominant theme is a divergence in management conviction: strong, consistent retention at Accenture versus significant profit-taking and de-risking by senior insiders at Synopsys and CrowdStrike.

10 high priority 10 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 06, 2026

This digest of 50 SEC filings reveals a market dominated by passive institutional stake adjustments and a few high-conviction activist and control events. The most significant development is the resolution of a proxy contest at Evogene Ltd., where an activist group secured four of seven board seats, signaling a major governance shift. Concurrently, Whitebox Advisors secured a board nomination right at KLX Energy Services after a $19M backstop exchange, while a new controlling shareholder took an 81.48% stake in AGM Group Holdings. On the institutional side, Wellington Management increased its stakes in Redwood Trust (to 17.0%) and Latham Group (to 10.2%), while Capital World Investors disclosed new or increased passive positions in Skyworks Solutions (10.1%), New Fortress Energy (12.2%), and Aura Minerals (10.2%). A notable pattern is the significant passive accumulation in SPACs by Wolverine Asset Management, which disclosed stakes in 10 different blank-check companies, suggesting a strategy of diversified arbitrage. The only clear exit signal came from Starboard Value, which liquidated its entire Qorvo stake following the Skyworks merger. Overall, the period shows a mix of passive rebalancing, targeted activist engagement, and a few transformative control transactions.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 06, 2026

The five filings in this S&P 500 Financials digest are dominated by routine insider transactions at Allstate Corp and a notable 10% owner sale at AFLAC, providing a narrow but actionable snapshot of management behavior in the insurance sub-sector. All four Allstate filings reflect standard equity compensation events—executives exercised restricted stock units and had shares withheld for taxes—with no material open-market buying or selling, indicating neutral sentiment and routine portfolio management. In contrast, AFLAC's 10% owner, Japan Post Holdings, executed a planned sale of 7,529 shares at $111.57 under a Rule 10b5-1 plan, signaling a pre-arranged, non-discretionary reduction that may weigh on sentiment despite its low materiality. Period-over-period comparisons and forward-looking guidance are absent from these filings, limiting trend analysis, but the insider activity patterns offer a clear view of management conviction: Allstate insiders are not actively accumulating, while AFLAC's largest holder is methodically reducing exposure. The lack of capital allocation changes, guidance updates, or scheduled events in this batch underscores a quiet period for these insurers, making the insider transactions the primary signal for investors to monitor.

5 high priority 5 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 06, 2026

The three S&P 500 Energy filings on October 6, 2026, reveal a sector in transition, balancing financial engineering with strategic portfolio reshaping. Expand Energy's credit facility extension to 2031 signals improved liquidity and lender confidence, while Chevron's divestiture of Hess Midstream and DJ Basin assets, despite a $3-4B one-time loss, indicates a strategic pivot away from midstream to focus on core E&P operations. SLB's board appointment of a former JPMorgan executive brings financial and Asian market expertise, potentially signaling a strategic focus on capital markets and Asia. No period-over-period financial trends were disclosed in these filings, limiting quantitative comparisons, but the capital allocation and governance moves suggest a sector prioritizing balance sheet strength and portfolio optimization. The absence of insider trading activity and forward guidance in these filings leaves the catalyst calendar sparse, with Chevron's divestiture closing by year-end 2026 as the primary near-term event.

2 high priority 1 medium 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 06, 2026

The six filings from the S&P 500 Consumer Staples sector reveal a mixed insider sentiment picture. Procter & Gamble shows a concentrated insider selling event: three senior executives (CFO, Chief Legal Officer, and CEO-Health Care) collectively sold over $1.2M in stock at $145.34, signaling potential leadership concern or portfolio rebalancing. In contrast, Hormel Foods presents a bullish insider signal with a director buying $201K worth of stock at $20.10, while a separate tax-withholding sale by a VP is routine. Kraft Heinz faces a key leadership departure as its Global General Counsel resigns effective October 20, 2026, creating a governance gap. No period-over-period or forward-looking data was provided in these filings, limiting trend analysis. The sector shows no capital allocation or transaction data in this batch. The key takeaway is a stark divergence in insider conviction between P&G (bearish selling) and Hormel (bullish buying), warranting close monitoring of P&G's next earnings call for underlying performance concerns.

6 high priority 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 06, 2026

The two filings in this digest provide limited but notable insights into the S&P 500 Industrials sector. Eaton Corp plc's Form 4 reveals insider activity by an executive, with a net share increase of 607 shares after exercising restricted stock units and withholding shares for taxes, indicating a modest but positive signal of management alignment. General Dynamics Corp's Schedule 13D/A shows a major activist investor, Longview Asset Management, maintaining a stable 9.0% stake with no change in intent, suggesting continued investor confidence. The lack of period-over-period financial comparisons or forward-looking guidance in these filings limits trend analysis, but the insider activity and stable large shareholder position are actionable signals. The sector appears to be in a period of stability with no major red flags, though the absence of operational data means investors should monitor upcoming earnings calls for more substantive insights.

2 high priority 2 total filings
· daily

US Material Events SEC 8-K Filings — October 06, 2026

The October 6, 2026, filings reveal a market sharply bifurcated between aggressive corporate restructuring and significant financial distress. A dominant theme is large-scale refinancing and balance sheet repair, with AMC Entertainment ($3.97B), HighPeak Energy ($1.25B), and Sysco ($18.5B for an acquisition) executing transformative capital markets transactions. Simultaneously, a wave of governance upheaval and financial fragility is evident, highlighted by the boardroom coup at Better Home & Finance and the auditor resignation at Ludwig Enterprises. M&A activity is robust, with IES Holdings ($691M) and Clarivate ($600M) completing major deals, while the SPAC Oceanhawk Acquisition continues its search for a target. The quarter-end period saw a flurry of credit agreement amendments, suggesting companies are proactively managing liquidity. Overall, the data points to a market where well-capitalized firms are aggressively pursuing growth and debt reduction, while weaker entities are resorting to dilutive financing and facing existential risks.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 06, 2026

Today's insider trading pulse reveals a stark bifurcation between aggressive insider buying in select value and special situations (Anteris Technologies, Borr Drilling, Sonic Automotive) and significant insider selling or tax-related dispositions across a broad swath of sectors, including technology, biotech, and professional services. The most notable cluster is the coordinated 'disposition to issuer' by five directors and officers at **Simulations Plus, Inc.**, totaling over $63M in stock and options, which strongly suggests a corporate event or buyout, not organic bearishness. While the overall sentiment is neutral-to-negative, driven by routine 10b5-1 plan sales and tax-withholding events, the high-conviction buys in energy services and auto retail signal targeted value plays. A key portfolio-level trend is the prevalence of 'award' transactions at **Accenture plc** and **Joby Aviation**, indicating standard equity compensation cycles rather than discretionary trading. The data also reveals a pattern of C-suite selling at **Kornit Digital** and **NWPX Infrastructure**, which, combined with their respective sector headwinds, warrants close monitoring. The most actionable intelligence comes from the Simulations Plus insider cluster, which demands immediate investigation into a potential M&A catalyst, and the large insider buys at Borr Drilling and Anteris Technologies, which suggest management sees significant undervaluation. The lack of forward-looking guidance changes in the filings limits the catalyst calendar, but the scheduled events and transaction details provide a rich tapestry for alpha generation.

46 high priority 4 medium 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 06, 2026

The October 6, 2026, filings for the DJIA 30 stream reveal a stark contrast between defensive consumer staples and the energy sector. Procter & Gamble shows a coordinated insider selling event, with three top executives (CFO, Chief Legal Officer, and CEO of Health Care) collectively divesting over $1.2 million in stock at $145.34, signaling potential bearish sentiment from management despite the stock's defensive nature. Meanwhile, Chevron announced a major strategic divestiture of its Hess Midstream and DJ Basin assets, expecting a substantial one-time after-tax loss of $3-$4 billion, which will materially impact near-term earnings. Sherwin-Williams saw routine director stock awards, indicating standard compensation practices with no strong directional signal. The primary themes are management profit-taking at P&G and a significant, value-destructive portfolio restructuring at Chevron, creating divergent risk profiles within the index.

7 high priority 1 medium 8 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 06, 2026

The October 6, 2026, corporate distress landscape is dominated by two Nasdaq compliance failures (FibroGen/Kyntra Bio and Virtuix Holdings), both receiving Staff Determinations on the same day (Sept 30, 2026) for failing to meet minimum market value and alternative financial standards. This clustering suggests a potential tightening of Nasdaq enforcement or a broader market-cap erosion among small-cap issuers. International Bancshares Corporation's voluntary delisting to the Texas Stock Exchange is a non-distress event and is excluded from further analysis. Neither distressed company provided period-over-period financial comparisons, forward guidance, or insider trading data in their 8-K filings, limiting quantitative trend analysis. The key actionable insight is the 180-day compliance window for both firms, creating a binary catalyst timeline. The lack of insider buying or capital allocation disclosures in these filings is itself a bearish signal, suggesting management is not signaling confidence through open-market purchases.

3 high priority 3 total filings
· daily

Global High-Priority Regulatory Events — October 06, 2026

The 50 filings reveal a concentrated wave of Indian corporate insolvencies (8+ companies entering CIRP, including Spright Agro, TV Vision, and Sun Granite Export), signaling severe distress in small-cap industrials and real estate. Healthcare M&A consolidation is a key theme, with Krishna Institute of Medical Sciences (KIMS) executing four acquisitions totaling up to ₹135 Cr, though most targets are loss-making, indicating a long-term strategic play. Large-cap M&A dominates in the US: IES Holdings acquired DBM Global for ~$691M (its largest deal), and Clarivate sold its Life Sciences segment for $600M to sharpen focus. SPAC activity remains active with Tavia Acquisition Corp's sponsor change and Melar Acquisition Corp's business combination vote set for October 22. Delisting risks are rising: FibroGen and Virtuix received Nasdaq non-compliance notices, while Bed Bath & Beyond's warrants were finally delisted. Period-over-period trends show extreme revenue collapses (Visagar Polytex from ₹71,017 lakh to zero) and rapid growth in early-stage companies (Meesho's investee revenue grew 6x to ₹16 Cr but remains unprofitable). The overall sentiment is predominantly negative or neutral, with only a few positive signals from well-capitalized acquirers.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 06, 2026

The October 6, 2026, filing slate is dominated by a single mega-cap M&A event: C.H. Robinson's $5.8 billion acquisition of RXO, creating a $25 billion enterprise value logistics powerhouse with $300 million in projected synergies. This deal overshadows a day otherwise characterized by capital structure maneuvers, including AMC's $3.97 billion refinancing and HighPeak Energy's $1.25 billion restructuring. A notable negative outlier is Blaize Holdings, which slashed its full-year revenue guidance by over 50% to $32-36 million, signaling severe operational distress. Insider activity was sparse but included a significant $4.87 million purchase in Anteris Technologies by a 10% owner, a bullish signal. The day also featured a controlling stake acquisition in AGM Group Holdings and a concerning reverse stock split plan from DarkIris Inc., highlighting a bifurcated market where large-cap strategic moves contrast with micro-cap distress.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 06, 2026

The sole filing in this stream is a Form 4 from DoorDash, Inc., revealing significant insider selling activity by Director Tang Stanley, who sold shares totaling approximately $1.19M at $188.87, while also acquiring a large block of 23,125 shares. The overall sentiment is negative, with a materiality score of 7/10, driven by the net selling pressure and the use of a Rule 10b5-1 plan, which suggests pre-planned, systematic selling rather than opportunistic. However, the director's substantial acquisition of 23,125 shares adds a nuanced, mixed signal, potentially indicating long-term confidence despite short-term profit-taking. The sales occurred at prices near $182-$189, which may reflect the stock trading at elevated levels, prompting insiders to lock in gains. With only one filing, portfolio-level trends are limited, but the insider activity pattern is notable for its scale and the mixed signals it presents. Investors should monitor DoorDash's upcoming earnings for guidance and any further insider transactions to gauge management's true conviction.

1 high priority 1 total filings